• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺腺癌中的DNA错配修复系统失衡

DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.

作者信息

Metaxas Georgios I, Tsiambas Evangelos, Marinopoulos Spyridon, Adamopoulou Maria, Spyropoulou Despoina, Falidas Evangelos, Davris Dimitrios, Manaios Loukas, Fotiades Panagiotis, Mastronikoli Sofianiki, Peschos Dimitrios, Dimitrakakis Constantine

机构信息

Breast Unit, 1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Department of Cytology, 417 VA (NIMTS) Hospital, Athens, Greece.

出版信息

Cancer Diagn Progn. 2023 Mar 3;3(2):169-174. doi: 10.21873/cdp.10197. eCollection 2023 Mar-Apr.

DOI:10.21873/cdp.10197
PMID:36875308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9949550/
Abstract

DNA mismatch repair system (MMR) is considered a leading genetic mechanism in stabilizing DNA structure and maintaining its function. DNA MMR is a highly conserved system in bacteria, prokaryotic, and eukaryotic cells, and provides the highest protection to DNA by repairing micro-structural alterations. DNA MMR proteins are involved in the detection and repair of intra-nucleotide base-to-base errors inside the complementary DNA strand recognizing the recently synthesized strand from the parental template. During DNA replication, a spectrum of errors including base insertion, deletion, and miss-incorporation negatively affect the molecule's structure and its functional stability. A broad spectrum of genomic alterations such as promoter hyper methylation, mutation, and loss of heterozygosity (LOH) in MMR genes including predominantly hMLH1, hMSH2, hMSH3, hMSH6, hPMS1, and hPMS2 lead to their loss of base-to-base error repairing procedure. Microsatellite instability (MSI) refers to the DNA MMR gene alterations that are observed in a variety of malignancies of different histological origins. In the current review, we present the role of DNA MMR deficiency in breast adenocarcinoma, a leading cancer-based cause of death in females worldwide.

摘要

DNA错配修复系统(MMR)被认为是稳定DNA结构和维持其功能的主要遗传机制。DNA错配修复是细菌、原核生物和真核细胞中高度保守的系统,通过修复微观结构改变为DNA提供最高级别的保护。DNA错配修复蛋白参与检测和修复互补DNA链内核苷酸之间的碱基错配,识别来自亲本模板的最近合成链。在DNA复制过程中,包括碱基插入、缺失和错掺入在内的一系列错误会对分子结构及其功能稳定性产生负面影响。多种基因组改变,如MMR基因(主要包括hMLH1、hMSH2、hMSH3、hMSH6、hPMS1和hPMS2)中的启动子高甲基化、突变和杂合性缺失(LOH),会导致其碱基错配修复过程丧失。微卫星不稳定性(MSI)指在不同组织学起源的多种恶性肿瘤中观察到的DNA错配修复基因改变。在本综述中,我们阐述了DNA错配修复缺陷在乳腺腺癌中的作用,乳腺腺癌是全球女性主要的癌症死亡原因。

相似文献

1
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.乳腺腺癌中的DNA错配修复系统失衡
Cancer Diagn Progn. 2023 Mar 3;3(2):169-174. doi: 10.21873/cdp.10197. eCollection 2023 Mar-Apr.
2
DNA mismatch repair deficiency in lung and oral cavity carcinomas: the role of histogenetic origin.肺癌和口腔癌中的DNA错配修复缺陷:组织发生学起源的作用
J BUON. 2017 May-Jun;22(3):606-609.
3
Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.胃癌细胞系中DNA错配修复蛋白的改变及微卫星不稳定性水平
Lab Invest. 2004 Jul;84(7):915-22. doi: 10.1038/labinvest.3700117.
4
Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌中DNA错配修复基因座hMSH2、hMLH1、hPMS1、hPMS2和hMSH3的等位基因失衡。
Oral Oncol. 2003 Feb;39(2):115-29. doi: 10.1016/s1368-8375(02)00028-3.
5
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.错配修复基因表达缺陷导致卵巢癌中的微卫星不稳定。
Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770.
6
Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor.源自单一肿瘤的错配修复缺陷的不同人子宫内膜癌细胞系的特征分析。
J Biol Chem. 1998 Oct 9;273(41):26662-9. doi: 10.1074/jbc.273.41.26662.
7
Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma.错配修复基因(hMLH1、hPMS1、hPMS2、GTBP/hMSH6、hMSH2)在肝细胞癌发病机制中的作用
World J Gastroenterol. 2005 May 28;11(20):3020-6. doi: 10.3748/wjg.v11.i20.3020.
8
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the Literature.急性髓系白血病中通过免疫组织化学评估微卫星不稳定性:文献的重新评估与综述
Clin Lymphoma Myeloma Leuk. 2022 Jun;22(6):e386-e391. doi: 10.1016/j.clml.2021.12.004. Epub 2021 Dec 9.
9
Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.结直肠癌中的微卫星不稳定性。免疫组织化学与分子生物学的比较表明hMSH6[校正为hMLH6]免疫染色的作用。
Arch Pathol Lab Med. 2003 Jun;127(6):694-700. doi: 10.5858/2003-127-694-MIICC.
10
The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma.错配修复基因 hPMS1(人减数分裂后分离 1)在口腔鳞状细胞癌中下调。
Gene. 2013 Jul 15;524(1):28-34. doi: 10.1016/j.gene.2013.04.030. Epub 2013 Apr 20.

引用本文的文献

1
Molecular Basis of Breast Tumor Heterogeneity.乳腺肿瘤异质性的分子基础
Adv Exp Med Biol. 2025;1464:237-257. doi: 10.1007/978-3-031-70875-6_13.
2
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application.肝细胞癌中 DNA 甲基化的综合回顾和最新分析:从基础研究到临床应用。
Clin Transl Med. 2024 Nov;14(11):e70066. doi: 10.1002/ctm2.70066.
3
DNA Methylation-Based Diagnosis and Treatment of Breast Cancer.基于DNA甲基化的乳腺癌诊断与治疗
Curr Cancer Drug Targets. 2025;25(1):26-37. doi: 10.2174/0115680096278978240204162353.

本文引用的文献

1
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer.雌激素受体β 1:女性三阴性乳腺癌的潜在治疗靶点。
Endocrinology. 2022 Oct 23;163(12). doi: 10.1210/endocr/bqac172.
2
Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.铂类药物与非铂类药物治疗三阴性乳腺癌的疗效:荟萃分析。
Eur J Med Res. 2022 Oct 15;27(1):201. doi: 10.1186/s40001-022-00839-0.
3
Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.基因组微卫星特征可识别种系错配修复缺陷和癌症发病风险。
J Clin Oncol. 2023 Feb 1;41(4):766-777. doi: 10.1200/JCO.21.02873. Epub 2022 Oct 14.
4
The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma.在浸润性小叶癌的管理中病理视角的重要性。
Breast J. 2022 Sep 26;2022:2461242. doi: 10.1155/2022/2461242. eCollection 2022.
5
The Present and Future of Clinical Management in Metastatic Breast Cancer.转移性乳腺癌临床管理的现状与未来
J Clin Med. 2022 Oct 5;11(19):5891. doi: 10.3390/jcm11195891.
6
Current Molecular Combination Therapies Used for the Treatment of Breast Cancer.目前用于治疗乳腺癌的分子联合疗法。
Int J Mol Sci. 2022 Sep 20;23(19):11046. doi: 10.3390/ijms231911046.
7
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making.新辅助化疗治疗的三阴性乳腺癌患者的BRCA突变状态:治疗决策中的关键作用
Cancers (Basel). 2022 Sep 21;14(19):4571. doi: 10.3390/cancers14194571.
8
Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.使用多种实验室方法对肿瘤中的错配修复进行临床检测。
Cancers (Basel). 2022 Sep 20;14(19):4550. doi: 10.3390/cancers14194550.
9
The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations.中美患者人群中癌症基因突变频率的比较。
Nat Commun. 2022 Sep 26;13(1):5651. doi: 10.1038/s41467-022-33351-4.
10
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.错配修复缺陷/微卫星不稳定结直肠肿瘤:诊断、预后和治疗。
Eur J Cancer. 2022 Nov;175:136-157. doi: 10.1016/j.ejca.2022.07.020. Epub 2022 Sep 14.